Lenalidomide Maintenance Treatment in Patients With Primary Central Nervous System Lymphoma
Condition: Central Nervous System Lymphoma Intervention: Drug: lenalidomide Sponsors: Seoul National University Bundang Hospital; Samyang BioPharm Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials